British Columbia Offers Immunotherapy Cancer Treatment

📆 3/11/2024 12:28 AM
📰 timescolonist

⏱ Reading Time:
13 sec. here
12 min. at publisher
📊 Quality Score:
News: 44%
Publisher: 75%

Health News

British Columbia,Immunotherapy,Cancer Treatment

British Columbia is beginning to offer an immunotherapy cancer treatment in the province for some patients who haven't had success with standard chemotherapy or radiation. Chimeric antigen receptor T-cell Therapy, commonly referred to as CAR-T, treats lymphoma and leukemia by collecting a patient's white blood cells and genetically engineering them to recognize and kill cancer cells. Dr. Kim Chi, the chief medical officer for BC Cancer, says patients who needed the treatment would previously have to be sent outside the province or country. Provincial Health Minister Adrian Dix says $14.3 million in this year's budget means up to 20 adults and five children will be able to get treatment at Vancouver General Hospital or BC Children's Hospital starting this month. Chi says the therapy is an example of how far cancer treatments have evolved, driven by "cutting edge" research and technology

British Columbia is now offering immunotherapy cancer treatment called CAR-T to patients who haven't had success with standard chemotherapy or radiation. The treatment genetically engineers a patient's white blood cells to recognize and kill cancer cells.

Previously, patients had to be sent outside the province or country for this treatment. $14.3 million in this year's budget will allow up to 20 adults and 5 children to receive treatment at Vancouver General Hospital or BC Children's Hospital.

Write Comment

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

British Columbia to Offer Immunotherapy Cancer TreatmentBritish Columbia is beginning to offer an immunotherapy cancer treatment in the province for some patients who haven’t had success with standard chemotherapy or radiation. Chimeric antigen receptor T-cell Therapy, commonly referred to as CAR-T, treats lymphoma and leukemia by collecting a patient’s white blood cells and genetically engineering them to recognize and kill cancer cells.
Source: CHEK_News - 🏆 59. / 55 Read more »